ReviewClinical kidney journal2024

Growing concerns about using hypoxia-inducible factor prolyl hydroxylase inhibitors for the treatment of renal anemia.

Takeshi Nakanishi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.